News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
3800
Sources here
20
Companies here
35
Search results Stored financial headlines

Active search

3800 matching headlines

Ticker or company: MEDIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

AMS secures shareholder support for planned sale to H.B. Fuller

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Advanced Medical Solutions Group's shareholders have approved the planned sale of the company to H.B. Fuller for 715 million pounds. …

AMS main company
Sharemaestro market context Trend signal active 52 weeks +35.1% AMS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates

Journey Medical (FBIO) reported a 23% year-over-year revenue increase to $18.5 million in Q2 2026, primarily driven by strong performance from its rosacea product, Emrosi, which generated $8.1 million in net revenue and saw a 20% sequential rise in prescriptions. The company achieved positive …

DERM main company
Sharemaestro market context Price above Trend Line 52 weeks -10.0% DERM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National CineMedia, Inc. (NASDAQ:NCMI) Given Average Rating of "Hold" by Brokerages

National CineMedia, Inc. (NASDAQ:NCMI) has received a consensus "Hold" rating from six analysts, with an average 12-month price target of $4.81. The company recently reported quarterly results that missed expectations, with a $0.10 per-share loss and revenue of $58.4 million. An insider sold 12,058 …

NCMI main company
Sharemaestro market context Trend signal active 52 weeks -35.3% NCMI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Utah Medical Products (NASDAQ:UTMD) Shares Pass Above 200 Day Moving Average - Time to Sell?

Utah Medical Products (NASDAQ:UTMD) shares have risen above their 200-day moving average, reaching $72.37 against an average of $66.51. The company reported quarterly earnings of $0.84 per share on $8.53 million in revenue and declared a $0.31 quarterly dividend, equivalent to a 1.7% annual …

UTMD main company
Sharemaestro market context Trend signal active 52 weeks +18.8% UTMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Asset Management One Co. Ltd. Purchases New Position in Medical Properties Trust, Inc. $MPT

Asset Management One Co. Ltd. has acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPT), purchasing 699,754 shares valued at approximately $3.23 million. This new position represents a 0.12% ownership in the company. Medical Properties Trust recently reported quarterly EPS of $0.15 and …

MPT main company
Sharemaestro market context Price below Trend Line 52 weeks +4.2% MPT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Key facts: MediWound Ltd. (MDWD) Q2 $3.09M rev; EscharEx $4B target

MediWound Ltd. (MDWD) reported Q2 2026 revenue of $3.09–3.10M, with a net loss of $7.39M and shares down 5.4% for the quarter. The company stated that its therapy, EscharEx, is targeting a $4 billion U.S. non-surgical tissue repair market, which it identifies as its …

MDWD main company
Sharemaestro market context Price below Trend Line 52 weeks -23.0% MDWD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Strata critical medical director Reginald Love disposes of $29,273 in stock

Reginald Love, a director at Strata Critical Medical (NASDAQ:SRTA), sold 5,091 shares of the company's Class A common stock for a total of $29,273 on August 10, 2026. Following this transaction, Love still directly holds 146,481 shares. The company's stock has seen significant gains …

SRTA main company
Sharemaestro market context Trend signal active 51 weeks +35.0% SRTA stored weekly price path from 29 Aug 2025 to 14 Aug 2026

CorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from Brokerages

CorMedix Inc (NASDAQ:CRMD) has received an average "Moderate Buy" rating from brokerages, with six out of eight analysts recommending a buy and two recommending a hold. The company's average 12-month price target is $14.86. This follows a strong second quarter where CorMedix beat revenue …

CRMD main company
Sharemaestro market context Trend signal ended 52 weeks -44.9% · Next-week setup positive 56.7% CRMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rockwell Medical Releases Q2 2026 Financial Results

Rockwell Medical, Inc. announced strong Q2 2026 financial results, significantly beating Wall Street expectations with an adjusted loss per share of $0.04 against an estimated $0.24 loss. The company reported revenue of $17.8 million, an 11% increase year-over-year, driven by expanding demand for its …

RMTI main company
Sharemaestro market context Price below Trend Line 52 weeks -35.0% · Next-week setup negative 41.3% RMTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Parabilis Medicines (PBLS) boosts cash above $1.1B after IPO and Regeneron deal

Parabilis Medicines, Inc. reported its Q2 2026 results, showing a significant increase in cash and cash equivalents to over $1.1 billion. This boost follows its June 2026 IPO, which generated $787.9 million in net proceeds, and a $50.0 million upfront payment from its collaboration …

PBLS main company
Sharemaestro market context Stored weekly price path 10 weeks +36.0% · Next-week setup positive 76.4% PBLS stored weekly price path from 12 Jun 2026 to 14 Aug 2026

SBC Medical Reports 13 Pct Rise In Q2 Revenue, Net Income Jumps 335 Pct

SBC Medical Group Holdings Inc. reported a 13% year-on-year increase in consolidated revenue to US$49 million for Q2 fiscal 2026, with net income surging by 335% to US$11 million. The company attributes this growth to strengthening underlying fundamentals, including the integration of healthcare and …

SBC main company
Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 38.5% SBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trump Media's CFO Sells Nearly 20,000 Shares After the Company's Crypto Business Combination Collapsed

Key Points The transaction involved 18,817 shares at a weighted average price of $8.33 per share, representing a total value of ~$157,000 on August 13, 2026. The move reduced the executive's direct equity holdings by 3% while maintaining a total beneficial position of ~582,000 …

DJT main company
Sharemaestro market context Price below Trend Line 52 weeks -53.7% DJT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates

MediciNova (MNOV) reported a Q2 loss of $0.05 per share, surpassing the Zacks Consensus Estimate of a $0.06 loss and improving from a $0.07 loss a year ago. The company also exceeded revenue estimates, posting $0.46 million against a $0.15 million consensus, though its …

MNOV main company
Sharemaestro market context Price below Trend Line 52 weeks -0.2% · Next-week setup negative 41.7% MNOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OUTFRONT Media (OUT), What Is Behind Its Latest Attention?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why OUTFRONT Media's latest earnings and deals matter for investors OUTFRONT Media (OUT) has been in focus after reporting second quarter 2026 results, raising …

OUT main company
Sharemaestro market context Trend signal active 52 weeks +65.6% OUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context